Chugai Pharmaceutical Co. Statistics
Total Valuation
CHGCY has a market cap or net worth of $61.08 billion. The enterprise value is $56.39 billion.
| Market Cap | 61.08B |
| Enterprise Value | 56.39B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
CHGCY has 3.29 billion shares outstanding.
| Shares Outstanding | 3.29B |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.01% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 29.02 and the forward PE ratio is 24.45. CHGCY's PEG ratio is 8.37.
| PE Ratio | 29.02 |
| Forward PE | 24.45 |
| PS Ratio | 9.53 |
| Forward PS | 0.05 |
| PB Ratio | 6.01 |
| P/FCF Ratio | 30.42 |
| PEG Ratio | 8.37 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.75, with an EV/FCF ratio of 28.08.
| EV / Earnings | 27.94 |
| EV / Sales | 8.80 |
| EV / EBITDA | 20.75 |
| EV / EBIT | 20.88 |
| EV / FCF | 28.08 |
Financial Position
The company has a current ratio of 5.53, with a Debt / Equity ratio of 0.00.
| Current Ratio | 5.53 |
| Quick Ratio | 4.21 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.02 |
| Interest Coverage | -88.32 |
Financial Efficiency
Return on equity (ROE) is 19.88% and return on invested capital (ROIC) is 19.40%.
| Return on Equity (ROE) | 19.88% |
| Return on Assets (ROA) | 17.20% |
| Return on Capital (ROIC) | 19.40% |
| Revenue Per Employee | $842,611 |
| Profits Per Employee | $265,430 |
| Employee Count | 7,604 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 1.21 |
Taxes
In the past 12 months, CHGCY has paid $727.72 million in taxes.
| Income Tax | 727.72M |
| Effective Tax Rate | 26.50% |
Stock Price Statistics
The stock price has increased by +30.98% in the last 52 weeks. The beta is 0.51, so CHGCY's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +30.98% |
| 50-Day Moving Average | 16.02 |
| 200-Day Moving Average | 17.23 |
| Relative Strength Index (RSI) | 73.04 |
| Average Volume (20 Days) | 86,679 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CHGCY had revenue of $6.41 billion and earned $2.02 billion in profits. Earnings per share was $1.23.
| Revenue | 6.41B |
| Gross Profit | 4.34B |
| Operating Income | 2.69B |
| Pretax Income | 2.75B |
| Net Income | 2.02B |
| EBITDA | 2.72B |
| EBIT | 2.70B |
| Earnings Per Share (EPS) | $1.23 |
Balance Sheet
The company has $4.73 billion in cash and $42.36 million in debt, giving a net cash position of $4.69 billion or $1.42 per share.
| Cash & Cash Equivalents | 4.73B |
| Total Debt | 42.36M |
| Net Cash | 4.69B |
| Net Cash Per Share | $1.42 |
| Equity (Book Value) | 10.15B |
| Book Value Per Share | 3.09 |
| Working Capital | 6.70B |
Cash Flow
In the last 12 months, operating cash flow was $2.38 billion and capital expenditures -$368.59 million, giving a free cash flow of $2.01 billion.
| Operating Cash Flow | 2.38B |
| Capital Expenditures | -368.59M |
| Free Cash Flow | 2.01B |
| FCF Per Share | $1.22 |
Margins
Gross margin is 67.67%, with operating and profit margins of 42.00% and 31.50%.
| Gross Margin | 67.67% |
| Operating Margin | 42.00% |
| Pretax Margin | 42.86% |
| Profit Margin | 31.50% |
| EBITDA Margin | 42.41% |
| EBIT Margin | 42.15% |
| FCF Margin | 31.34% |
Dividends & Yields
CHGCY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | -0.01% |
| Earnings Yield | 3.30% |
| FCF Yield | 3.29% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 6, 2020. It was a forward split with a ratio of 12:1.
| Last Split Date | Jul 6, 2020 |
| Split Type | Forward |
| Split Ratio | 12:1 |
Scores
CHGCY has an Altman Z-Score of 26.27 and a Piotroski F-Score of 6.
| Altman Z-Score | 26.27 |
| Piotroski F-Score | 6 |